Details for Patent: 9,205,075

Which drugs does patent 9,205,075 protect, and when does it expire?

Patent 9,205,075 protects MITOSOL and is included in one NDA.

This patent has nine patent family members in five countries.

Summary for Patent: 9,205,075

Title:	Apparatus and method for reconstituting a pharmaceutical and preparing the reconstituted pharmaceutical for transient application
Abstract:	An apparatus and method for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in at least one absorbent pad. The absorbent pads may come in multiple shapes and or/sizes. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.
Inventor(s):	Timm; Edward J. (Cumming, GA)
Assignee:	MOBIUS THERAPEUTICS, LLC (St. Louis, MO)
Application Number:	13/445,654
Patent Claim Types: see list of patent claims	Composition; Formulation; Device;

Drugs Protected by US Patent 9,205,075

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mobius Therap	MITOSOL	mitomycin	FOR SOLUTION;TOPICAL	022572-001	Feb 7, 2012		RX	Yes	Yes			Y

International Family Members for US Patent 9,205,075

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2007272514
Canada	2659314
European Patent Office	2046653
European Patent Office	3175843